Page 2 - Diego Based Dexcom News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Major players in the diabetes space could join forces as Dexcom (Nasdaq:DXCM) is reportedly in discussions to acquire Insulet (Nasdaq:PODD).

Dexcom (Nasdaq:DXCM) announced today that its board of directors approved a four-for-one forward split of the company’s common stock.

An Abbott Laboratories subsidiary focused on diabetes care sued rival DexCom in Delaware federal court for allegedly violating a 2014 settlement agreement and asked the court to declare that Abbott doesn't infringe its patents.

MedCity News Abbott gets FDA clearance for CGM app Abbott received FDA clearance for an app to pair with its Freestyle Libre 2 glucose monitor. The app lets people get readings directly on their phone without using a reader. Shares0 The iPhone app would let people get glucose readings directly on their phone without using a reader. Users can scan a sensor built into the Freestyle Libre 2 to get their current glucose reading and trends. They can also share glucose readings and real-time alarms with caregivers. The app is cleared to be used by both adults and children, ages 4 and up.

San Diego-based Dexcom, which develops equipment for continuous glucose monitoring for people with diabetes, has launched its own venture capital fund, Dexcom Ventures. According to Dexcom, the new fu